Oncogene - Table of Contents alert Volume 31 Issue 17

TABLE OF CONTENTS Volume 31, Issue 17 (April 2012) In this issue Review Original Articles Also new AOP Advertisement Cancer Models You've Been Looking For • Broadest portfolio of immunodeficient mice & rats, including the CIEA NOG mouse® • Spontaneous tumor models including breast & colon • Xenogeneic, syngeneic, ectopic, orthotopic or metastatic in vivo models using over 400 cancer cell lines • Patient-derived tumor xenografts (Offered by Taconic in collaboration with Oncodesign) Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Leukemia SPOTLIGHTS - focusing on topical research in the field of leukemia and allied diseases. Have you read the latest collections? miRNA and Hematopoiesis Guest Editor: Dr. Monique L. den Boer Signaling pathways regulating HSC Guest Editor: Prof. F Staal Explore the full series at www.nature.com/leu/spotlights   Review Top Breast cancer genome-wide association studies: there is strength in numbers D Fanale, V Amodeo, L R Corsini, S Rizzo, V Bazan and A Russo Oncogene 2012 31: 2121-2128; advance online publication, September 26, 2011; 10.1038/onc.2011.408 Abstract | Full Text Original Articles Top Manganese superoxide dismutase is a mitochondrial fidelity protein that protects Polγ against UV-induced inactivation V Bakthavatchalu, S Dey, Y Xu, T Noel, P Jungsuwadee, A K Holley, S K Dhar, I Batinic-Haberle and D K St Clair Oncogene 2012 31: 2129-2139; advance online publication, September 12, 2011; 10.1038/onc.2011.407 Abstract | Full Text Development of a Listeria monocytogenes-based vaccine against hepatocellular carcinoma Y Chen, D Yang, S Li, Y Gao, R Jiang, L Deng, F R Frankel and B Sun Oncogene 2012 31: 2140-2152; advance online publication, September 19, 2011; 10.1038/onc.2011.395 Abstract | Full Text Overexpression of androgen receptor enhances the binding of the receptor to the chromatin in prostate cancer A Urbanucci, B Sahu, J Seppälä, A Larjo, L M Latonen, K K Waltering, T L J Tammela, R L Vessella, H Lähdesmäki, O A Jänne and T Visakorpi Oncogene 2012 31: 2153-2163; advance online publication, September 12, 2011; 10.1038/onc.2011.401 Abstract | Full Text The BMP2/7 heterodimer inhibits the human breast cancer stem cell subpopulation and bone metastases formation J T Buijs, G van der Horst, C van den Hoogen, H Cheung, B de Rooij, J Kroon, M Petersen, P G M van Overveld, R C M Pelger and G van der Pluijm Oncogene 2012 31: 2164-2174; advance online publication, September 26, 2011; 10.1038/onc.2011.400 Abstract | Full Text The oncogenic phosphatase PPM1D confers cisplatin resistance in ovarian carcinoma cells by attenuating checkpoint kinase 1 and p53 activation A Y Ali, M R Abedini and B K Tsang Oncogene 2012 31: 2175-2186; advance online publication, September 19, 2011; 10.1038/onc.2011.399 Abstract | Full Text Mucin 1 enhances the tumor angiogenic response by activation of the AKT signaling pathway J K Woo, Y Choi, S-H Oh, J-H Jeong, D-H Choi, H-S Seo and C-W Kim Oncogene 2012 31: 2187-2198; advance online publication, September 19, 2011; 10.1038/onc.2011.410 Abstract | Full Text E6AP is required for replicative and oncogene-induced senescence in mouse embryo fibroblasts Y Levav-Cohen, K Wolyniec, O Alsheich-Bartok, A-L Chan, S J Woods, Y-H Jiang, S Haupt and Y Haupt Oncogene 2012 31: 2199-2209; advance online publication, September 19, 2011; 10.1038/onc.2011.402 Abstract | Full Text Key role of ATF3 in p53-dependent DR5 induction upon DNA damage of human colon cancer cells K Taketani, J Kawauchi, M Tanaka-Okamoto, H Ishizaki, Y Tanaka, T Sakai, J Miyoshi, Y Maehara and S Kitajima Oncogene 2012 31: 2210-2221; advance online publication, September 19, 2011; 10.1038/onc.2011.397 Abstract | Full Text G1P3, an interferon- and estrogen-induced survival protein contributes to hyperplasia, tamoxifen resistance and poor outcomes in breast cancer V Cheriyath, M A Kuhns, B S Jacobs, P Evangelista, P Elson, E Downs-Kelly, R Tubbs and E C Borden Oncogene 2012 31: 2222-2236; advance online publication, September 26, 2011; 10.1038/onc.2011.393 Abstract | Full Text Loss of breast epithelial marker hCLCA2 promotes epithelial-to-mesenchymal transition and indicates higher risk of metastasis V Walia, Y Yu, D Cao, M Sun, J R McLean, B G Hollier, J Cheng, S A Mani, K Rao, L Premkumar and R C Elble Oncogene 2012 31: 2237-2246; advance online publication, September 12, 2011; 10.1038/onc.2011.392 Abstract | Full Text Advertisement Call for papers! Submit your best work in cancer research, including mechanisms of cellular oncogene activation, structure and function of encoded proteins, DNA and RNA tumor viruses and all other aspects of oncogene structure and function. Our online submission process is easy and can assist you in becoming part of this distinguished journal. Visit our Author page to learn about the benefits of publishing in the Journal and for guidelines on how to submit your paper.   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.